This risk assessment evaluates the risk of yellow fever infection, which has seen outbreaks in Angola, Democratic Republic of Congo and Uganda, being introduced into Europe, and sets out a range of options for response.

This rapid risk assessment assesses the ongoing outbreak of yellow fever in Brazil and the subsequent risk to EU/EEA countries and citizens.

In September 2017, the Ministry of Health in Brazil declared the end of the 2016–2017 yellow fever outbreak in the country. The upsurge of human cases since December 2017 and the continuous non-human primate epizootics since September 2017 indicate a continued or resumed increase in yellow fever virus circulation in Brazil. Since January 2018, most of the yellow fever cases have been reported from São Paulo, Rio de Janeiro and Minas Gerais states.

This risk assessment evaluates the risk of yellow fever infection being introduced into Europe and sets out a range of options for response.

This risk assessment contains updated advice to travellers and health professionals and the latest information on the epidemiological situation of yellow fever in Brazil.

This publication assesses the risk to EU/EEA countries and citizens associated with the ongoing outbreak of yellow fever in Brazil. This is the second update of a rapid risk assessment originally produced on 25 January 2017 and updated on 13 April 2017.

This risk assessment is triggered by the increase in the number of yellow fever cases among EU travellers with exposure in South America since August 2016 and assesses the risk of contracting yellow fever for travellers to South America.

This document assesses the risk of yellow fever infections in Europe related to the ongoing outbreak of yellow fever in Angola, and the notification of imported cases in China and possibly Mauritania.